Charles River Laboratories International (CRL) Net Cash Flow Growth (3y) (2012 - 2026)
Powered by 
Analysis
Charles River Laboratories International (CRL) Net Cash Flow Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 27.97% |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | -164.05% |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 168.48% |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 858.59% |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 63.95% |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 42.13% |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 53.91% |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -46.25% |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 27, 2026 | 858.59% |
| Mar 28, 2026 | 17.56% |
| Dec 27, 2025 | -54.47% |
| Sep 27, 2025 | 65.11% |
| Jun 28, 2025 | -13.13% |
| Mar 29, 2025 | 64.03% |
| Dec 28, 2024 | -27.78% |
| Sep 28, 2024 | 162.09% |
| Jun 29, 2024 | 14.84% |
| Mar 30, 2024 | -34.96% |
| Dec 30, 2023 | 137.79% |
| Sep 30, 2023 | 38.91% |
| Jul 1, 2023 | -88.17% |
| Apr 1, 2023 | -31.10% |
| Dec 31, 2022 | -24.72% |
| Sep 24, 2022 | 34.41% |
| Jun 25, 2022 | -36.66% |
| Mar 26, 2022 | 51.32% |
| Dec 25, 2021 | -34.46% |
| Sep 25, 2021 | 71.64% |